The epidemiology and therapeutic options for the COVID-19

13Citations
Citations of this article
56Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

An outbreak of coronavirus disease 2019 (COVID-19), a disease caused by a novel pneumonia virus, has affected over 200 countries and regions worldwide. With the increasing number of patients and deaths, WHO have declared it as a global pandemic currently, indicating a third large-scale epidemic coronavirus has appeared since the emergence of severe acute respiratory syndrome coronavirus (SARS) and Middle-East respiratory syndrome (MERS) in the twenty-first century. Considering the great harm it has caused, researchers throughout the world have been chasing to exploit the pathophysiology, characteristics, and potential remedies for COVID-19 to better battle the outbreak. Therefore, the current study revisits advances of the virology, epidemiology, clinical features, therapeutic options, and prevention of COVID-19. The features of asymptomatic carriers are also been explored.

Cite

CITATION STYLE

APA

Li, J., Shao, J., Wang, C., & Li, W. (2020, June 1). The epidemiology and therapeutic options for the COVID-19. Precision Clinical Medicine. Oxford University Press. https://doi.org/10.1093/pcmedi/pbaa017

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free